Page last updated: 2024-11-08

indole-3-acetonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

indole-3-acetonitrile: occurs in edible cruciferous vegetables [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

indole-3-acetonitrile : A nitrile that is acetonitrile where one of the methyl hydrogens is substituted by a 1H-indol-3-yl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID351795
CHEMBL ID1812654
CHEBI ID17566
SCHEMBL ID149254
MeSH IDM0066557

Synonyms (79)

Synonym
BIDD:GT0196
ai3-50105
3-indolacetonitrile
einecs 212-232-1
ccris 5807
nsc 523272
brn 0125488
EN300-20368
CHEBI:17566 ,
1h-indol-3-ylacetonitrile
1h-indole-3-acetonitrile
3-(cyanomethyl)indole
indoleacetonitrile
nsc523272
3-indolylacetonitrile
wln: t56 bmj d1cn
acetonitrile, 3-indolyl-
indolylacetonitrile
usaf cb-29
nsc-523272
indolylacetonitril
indole-3-acetonitrile
771-51-7
indol-3-ylacetonitrile
3-indoleacetonitrile ,
(indol-3-yl)acetonitrile
C02938
3-indoleacetonitrile, 98%
I-5650
indole-3-ylacetonitrile
IAN ,
71C17B3A-CA19-4822-A4E7-D424F7074B4C
beta-indole-3-acetonitrile
AC-10572
dmcpfobljmlsnx-uhfffaoysa-
inchi=1/c10h8n2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12h,5h2
BMSE000488
(indole-3-yl)acetonitrile
(3-indolyl)acetonitrile
2-(1h-indol-3-yl)acetonitrile
I0024
STK802120
AKOS000120379
A838975
2-(1h-indol-3-yl)ethanenitrile
CHEMBL1812654 ,
2-(1h-indol-3-yl)-acetonitrile
bdbm50350241
BRD-K65452854-001-01-5
5-22-03-00074 (beilstein handbook reference)
ag97ofw8jw ,
unii-ag97ofw8jw
PS-3276
S6043
SCHEMBL149254
MB00159
2(1h-indol-3-yl)acetonitrile
1h-indole-3-ylacetonitrile
3-cyanomethyl-1h-indole
3-cyanomethylindole
(1h-indol-3-yl)acetonitrile
(1h-indol-3-yl)-acetonitrile
DTXSID5061118
indolyl-3-acetonitrile
.beta.-indoleacetonitrile
1h-indol-3-ylacetonitrile #
mfcd00005628
CS-W008768
3-indoleacetonitrile, purum, >=96.0% (gc)
3-indolyl-acetonitrile
beta-indoleacetonitrile
3bo ,
Q27102461
b-indoleacetonitrile
AMY871
HY-Y0136
GLXC-26570
PD124092
Z104477894
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
auxinAny of a group of compounds, both naturally occurring and synthetic, that induce cell elongation in plant stems (from Greek alphaupsilonxialphanuomega, "to grow").
plant hormoneA plant growth regulator that modulates the formation of stems, leaves and flowers, as well as the development and ripening of fruit. The term includes endogenous and non-endogenous compounds (e.g. active compounds produced by bacteria on the leaf surface) as well as semi-synthetic and fully synthetic compounds.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
indolesAny compound containing an indole skeleton.
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
indole-3-acetate biosynthesis II820
indole glucosinolate activation (herbivore attack)320
Camalexin Biosynthesis821
camalexin biosynthesis318
4-hydroxyindole-3-carbonyl nitrile biosynthesis413
indole-3-acetate biosynthesis IV (bacteria)07
indole-3-acetate biosynthesis V (bacteria and fungi)18
indole-3-acetate biosynthesis II621
indole glucosinolate activation (herbivore attack)424
IAA biosynthesis I025
IAA biosynthesis V65
IAA biosynthesis I021

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tryptophan 2,3-dioxygenaseMus musculus (house mouse)IC50 (µMol)80.00001.00002.48675.0000AID611916
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID674375Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674376Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674374Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674373Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID611917Cytotoxicity against mouse P815B cells after 8 hrs by MTT assay2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
AID674377Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674370Antiviral activity against HIV1 infected in 293T cells cotransfected with VSV-G at 10 uM after 48 hrs by ELISA2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674371Antiviral activity against Herpes simplex virus 1 at 10 uM2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674372Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID611916Inhibition of mouse TDO expressed in mouse P815B cells assessed as inhibition of tryptophan catabolism by measuring kynurenine production after 8 hrs by HPLC analysis2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (56)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (8.93)18.7374
1990's8 (14.29)18.2507
2000's15 (26.79)29.6817
2010's23 (41.07)24.3611
2020's5 (8.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.44 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (98.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]